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Wounding-Induced Synthesis of Hyaluronic Acid in
Organotypic Epidermal Cultures Requires the Release
of Heparin-Binding EGF and Activation of the EGFR
James Monslow1, Nobuyuki Sato1,3, Judith A. Mack1 and Edward V. Maytin1,2
Hyaluronic acid (HA), a glycosaminoglycan located between keratinocytes in the epidermis, accumulates
dramatically following skin wounding. To study inductive mechanisms, a rat keratinocyte organotypic culture
model that faithfully mimics HA metabolism was used. Organotypic cultures were needle-punctured 100 times,
incubated for up to 24hours, and HA analyzed by histochemical and biochemical methods. Within 15minutes
post-injury, HA levels had elevated two-fold, increasing to four-fold by 24 hours. HA elevations far from the site
of injury suggested the possible involvement of a soluble HA-inductive factor. Media transfer experiments
(from wounded cultures to unwounded cultures) confirmed the existence of a soluble factor. From earlier
evidence, we hypothesized that an EGF-like growth factor might be responsible. This was confirmed as follows:
(1) EGFR kinase inhibitor (AG1478) completely prevented wounding-induced HA accumulation. (2) Rapid
tyrosine-phosphorylation of EGFR correlated well with the onset of increased HA synthesis. (3) A neutralizing
antibody that recognizes heparin binding EGF-like growth factor (HB-EGF) blocked wounding-induced HA
synthesis byX50%. (4) Western analyses showed that release of activated HB-EGF (but neither amphiregulin nor
EGF) occured after wounding. In summary, rapid HA accumulation after epidermal wounding occurs through a
mechanism requiring cleavage of HB-EGF and activation of EGFR signaling.
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INTRODUCTION
Hyaluronic acid (HA; also called hyaluronan) is a high
molecular weight carbohydrate polymer that plays a role in
tissue growth, development, wound healing, and inflamma-
tion. HA consists of a disaccharide unit (-b1,4-glucuronic
acid-b1,3-N-acetylglucosamine-) repeated several thousand
times. HA can be considered an ‘‘honorary proteoglycan,’’
that is, a pure glycosaminoglycan without any protein
component. Owing to its tremendous size (over 2 million
Daltons) and unusual physiochemical properties that allow it
to retain large amounts of solvent, HA is an important
molecule with space-filling, lubricating, and filtering func-
tions in connective tissues. With no sulfate groups or other
charge modifications, HA might, at first glance, appear to be
a passive molecule. However, HA is actually very dynamic,
interacting with specific proteins in the matrix and with
receptors on the cell surface to mediate physiological
changes in cells and tissues (Hascall and Laurent, 1997;
Day and Prestwich, 2002; Toole et al., 2002; Turley et al.,
2002; Hascall et al., 2004).
The effects of HA on living cells in tissues can be
profound. A high level of HA in the extracellular matrix
promotes proliferation and migration of normal cells, as well
as invasion and metastases of malignant cells (Toole et al.,
2002). Low levels of HA, on the other hand, tend to correlate
with cellular differentiation (Agren et al., 1997; Toole et al.,
2002). In general, the extracellular matrix becomes enriched
in HA during episodes of rapid cellular migration and
proliferation, both in developing and in regenerating tissues.
HA-rich matrices also have the capacity to bind growth
factors, which in turn can influence both cell growth and
differentiation by manipulating local concentrations of the
factors. High levels of HA in embryonic and fetal tissues are
essential during embryonic development. For example, mice
lacking the gene for HA synthase 2 (Has2), a major synthetic
enzyme for HA, show striking defects in cardiac development
owing to failure in the epithelial-mesenchymal transition
(Camenisch et al., 2000).
An important question is whether or not HA is essential for
the cellular migration and proliferation that occurs in a
healing wound. Much evidence supports this notion. For
example, large amounts of HA are found in healing skin,
especially at early stages of tissue repair (West et al., 1997).
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The high levels of HA are found in both dermal and
epidermal components of the skin. HA is a major component
of early granulation tissue, and fibroblasts isolated from early
wounds produce more HA than do fibroblasts from normal
skin ((Clark, 1996), page 27). High levels of HA correlate with
improved repair and scarless wound healing in both fetal
sheep (West et al., 1997) and in mice (Mack et al., 2003). In
the epithelial layer (epidermis), it has been shown that levels
of HA are increased for many days following disruption of the
epidermis by tape stripping (Tammi et al., 2005). Injury to the
stratum corneum of the skin by friction and solvents (so-
called ‘‘barrier injury’’) leads to accumulations of HA nearly
as large in magnitude as those seen after mechanical
wounding (Maytin et al., 2004). As wounding of the skin
causes the release of proinflammatory cytokines (Wood et al.,
1992; Clark, 1996), and because cytokines and other peptide
factors are known to stimulate increased transcription of HA-
synthetic enzymes (Pienimaki et al., 2001; Karvinen et al.,
2003), it appears likely that wounding-stimulated production
of such factors might participate in the increased levels of HA
that one sees in the skin. Once produced, HA in its native
form interacts with cell-surface receptors (CD44 and
RHAMM) to regulate intracellular signaling (Turley et al.,
2002), or the HA can be degraded into small fragments (by
hyaluronidase (Hyal) enzymes) and interacted with toll-like
receptors on cell surfaces (Taylor et al., 2004). Changes in HA
expression that occur in injured tissues can have profound
effects upon the migration and activation of inflammatory
cells, including monocytes and macrophages (reviewed by
Hascall et al., 2004). Therefore, injury-induced changes in
HA are likely to be critical for regulating the influx of
inflammatory cells that occur immediately after wounding of
the skin.
Despite the abundance and apparent importance of
cutaneous HA, relatively little is actually known about
the mechanisms that govern its synthesis and degradation
in the skin, or about the functional impact of changes in
HA expression. As the epidermis (outer epithelial layer)
of the skin serves as the primary environmental barrier in
vertebrates, with dire consequences in terms of severe
infection and fluid loss when the epidermis is disrupted, we
have been focusing our studies on understanding HA
metabolism and function in this tissue. To avoid some of
the uncontrollable variables associated with whole-animal
studies, we used an in vitro three-dimensional (3D)
model (organotypic epidermal cultures) in which immorta-
lized rat epidermal keratinocytes (REKs) are allowed to
stratify on a collagen substrate in the absence of fibroblasts.
This system generates a multi-layered epidermal tissue
with the same morphological features, functional barrier
properties, and responses to barrier injury as the native
epidermis (Tammi et al., 2000; Pasonen-Seppanen et al.,
2001; Passi et al., 2004; Ajani et al., 2007). As our model
epidermis has a fully intact basement membrane beneath
the keratinocytes and an impervious stratum corneum
at the top (Tammi et al., 2000), any HA produced by the
epidermal cells remains entirely within the epidermal
compartment, mimicking the situation of the true epidermis
in vivo (Passi et al., 2004). In this article, we use the
organotypic model to investigate the mechanisms of HA
induction in response to mechanical injury (puncture
wounding) of the epidermal tissue. Our data show significant
changes in HA levels, and elucidate a response whereby
mechanical injury leads to the release of a soluble factor that
mediates an increased synthesis of HA in distant cells. A
major component of this soluble signal turns out to be the
well-known growth factor, heparin binding EGF-like growth
factor (HB-EGF).
RESULTS
Induction of epidermal HA levels after skin wounding can be
modeled in REK 3D organotypic cultures
Scalpel injury of native skin causes a robust increase in
epidermal HA, with highly elevated levels of HA seen at the
edges of the wound (Figure 1). In vivo, these increases are first
detectable within 24 hours (data not shown), reach a
maximum within 3 days (Figure 1b), start to decline by
1 week (Figure 1c), and completely resolve by 2 weeks
(Figure 1d). To replicate this phenomenon in the organotypic
model, REK lift cultures were injured by evenly-spaced
needle punctures (100 stabs administeredB2mm apart over
the surface of the culture; see Materials and Methods) and
then analyzed histologically using a ‘‘cigarette roll’’ method,
followed by immunochemical staining for HA. Increased HA
levels were seen within 2 hours (Figure 1g), and rose steadily
at 6 and 24 hours (Figure 1h and i). Specificity of the HA-
binding probe was shown by pre-digesting the tissue speci-
mens with two different bacterial Hyals, each of which
abrogated the signal (Figure 1j–l).
Following a peak at 24 hours after injury, HA levels
declined at 48 and 72 hours (Figure 2a, closed circles). To
rule out the possibility that increases in HA might be because
of stress or changes in carbohydrate metabolism related to
manipulation of the cultures during puncture, the experiment
was conducted using time-matched sham controls that were
handled identically, except for receiving no needle injury; no
significant induction of HA was observed in the control
cultures (Figure 2a, open circles).
We wished to find out whether accumulation of HA in the
lift cultures occurs only locally at the site of injury, or
whether the effects of injury are more widespread. As an
initial approach, we compared two patterns of injury, one
in which 100 needle punctures were delivered evenly
over the entire culture surface (Figure 2b, open squares),
versus a more localized pattern in which the punctures
were delivered in a few closely-spaced rows down the center
of the culture (Figure 2b, closed diamonds). In both cases,
HA induction was observed throughout the culture, and
in the cultures receiving localized injury, HA induction
was observed at least 1 cm away from the nearest puncture
site. Two formal possibilities to explain stimulation
of HA accumulation at such a distance include (i) the
production and release of a soluble paracrine factor; and
(ii) a juxtacrine or biomechanical inductive effect
between cells. In this article, we have examined the first
possibility.
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The induction of epidermal HA is mediated by a soluble factor
To test the hypothesis that a soluble factor may be responsible
for wounding-induced accumulation of HA, experiments
were designed as in Figure 3. Paired sets of ‘‘donor’’ and
‘‘recipient’’ organotypic cultures were used for these studies.
Keratinocytes were seeded, grown submerged for 2 days to
achieve confluency, then lifted for 5 days to the air interface
to promote stratification. At the desired time before harvest,
the donor cultures were injured with a needle (at the time,
labeled ‘‘puncture’’ in Figure 3) and at the end of day 7,
harvested for HA analysis. Concurrently, conditioned media
from the donor cultures were transferred to corresponding
recipient cultures (Figure 3). Recipient cultures were
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Figure 1. Levels of HA are increased after epidermal wounding in the skin (in vivo) and in REK lift cultures (in vitro). (a–e) Staining of HA in wounded skin.
Anesthetized C57BL/6J mice were wounded with a scalpel, and at designated times post-wounding, the skin was biopsied, fixed in paraffin, and processed for
histochemical staining using biotinylated HA-binding protein (HABP) and avidin-conjugated Cy3 (bright signal). Photomicrographs were taken immediately
lateral to the wound edge (for example, asterisk in panel b). Locations of epidermis and dermis are shown. Vertical arrows, height of epidermis. Dotted line,
dermal–epidermal junction. Bar, 100mm. (f–i) Staining of HA in REK organotypic cultures after puncture wounding. Following puncture injury with a 28-gauge
needle, cultures were incubated for the times indicated, harvested, paraffin-embedded, and stained with biotinylated HABP/Cy3 (bright signal). Arrowheads,
location of basement membrane. Bar, 50 mm. (j–l) Experiment to show HA-specificity of HABP staining. Three paraffin sections from the same needle-injured REK
specimen were incubated overnight with (j) saline, (k) Streptomyces hyaluronidase, or (l) S. dysgalactiae hyaluronidase, then stained with HABP (see Materials
and Methods for details).
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Figure 2. Time course of induction of HA levels following puncture
wounding of REK lift cultures. (a) Change in HA signal in wounded cultures
relative to time-matched uninjured control cultures, as a function of time
(logarithmic scale) after injury. Data from wounded cultures (closed circles) or
unwounded controls (open circles) are expressed relative to uninjured time
zero controls. HA fluorescent stain intensity was quantified using image
processing as described in Materials and Methods. Data are pooled between
three and five experiments per time point, and reported as the mean±SD.
(b) The magnitude and location of increases in HA are independent of the site
of injury. A 28-gauge needle was used to deliver the punctures in either a
random, global pattern (open squares) or in a focal (central linear) pattern
(closed diamonds) over the surface of the culture. The cultures were
harvested, stained with HABP/Cy3, and relative HA levels throughout the
culture were quantified by image processing. Bars represent the mean±range
of two experiments.
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Figure 3. Protocol for media transfer experiments. Time line for experiments
involving puncture injury of REK lift cultures, followed by transfer of the
culture media to uninjured recipient cultures. (See text.)
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incubated for a further 24 hours and then harvested for HA
analysis. To control the effects of glucose depletion (knowing
that rapid HA turnover is a major contributor to glucose
consumption in REK lift cultures (Tammi et al., 2001; Passi
et al., 2004), the culture media were changed daily and the
experimental design (Figure 3) ensured that all cultures were
in a given medium for identical periods of time.
The results of media transfer experiments in which HA was
detected immunochemically are illustrated in Figure 4. In the
punctured donor cultures, a significant increase in HA was
observed at 15minutes after injury, and HA levels continued
to rise at 6 and 24 hours (Figure 4a, left side, and Figure 4b,
open bars). In the uninjured recipient cultures, exposure to
conditioned medium derived from the donor cultures caused
a strong HA induction (Figure 4a, right side), confirming our
prediction of a bioactive factor in the media. HA levels
achieved in the recipient cultures after 24 hours exposure to
conditioned medium (Figure 4b, closed bars) were essentially
identical to the HA level reached in donor cultures 24 hours
after injury (dotted line), suggesting that all factor(s) that are
released into the medium exert a similar HA-elevating effect
in both sets of cultures.
To confirm these apparent changes in HA by an
independent method, we analyzed the organotypic cultures
using a biochemical technique called FACE (fluorophore-
assisted carbohydrate electrophoresis). This method quanti-
fies the total mass of HA in a sample by enzymatic
degradation to the minimal disaccharide unit, followed by
separation on an acrylamide gel (Figure 5, top panels).
During media transfer experiments, the total amount of HA in
both the injured cultures (Figure 5a) and the recipient cultures
(Figure 5b) was significantly increased as a result of puncture
injury.
Wounding leads to increased expression of Has enzymes
Hyaluronic acid accumulation after wounding might be the
net result of increased synthesis, decreased degradation, or
both. To distinguish between these potential mechanisms,
expression of all major mammalian HA synthetic enzymes
and catabolic enzymes was measured by reverse transcrip-
tion-PCR. In a slightly modified version of the protocol in
Figure 3, donor cultures were harvested at 6 hours after
puncture and recipient cultures were harvested at 6 hours
after media transfer. The mRNA levels of Has enzymes (Has1,
Has2, and Has3) and Hyal enzymes (Hyal1, Hyal2, and
Hyal3) were measured using rat-specific primers designed to
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Figure 4. HA production is increased in normal REK lift cultures treated with
conditioned medium from injured cultures. Donor cultures were punctured
in a random pattern, and the medium was conditioned for various times
(0 hour, 15minutes, 6, or 24 hours) before being transferred to a second set of
cultures on day 7. The donor cultures were harvested, whereas the recipient
cultures were incubated for another 24 hours before harvest (see Figure 3 for
protocol). (a) Immunofluorescent micrographs of 5 mm sections of paraffin-
fixed REK cultures following staining with bHABP and Cy3-avidin for
detection of HA (bright signal). Bar, 50 mm. (b) Quantitation of the relative
increase in HA in the donor cultures as a function of time, determined by
image processing of digital micrographs. Data are pooled from two
experiments, 10 microscopic fields per experiment, mean±range. Note that
HA levels achieved in the recipient cultures (closed bars) after 24 hours in
conditioned medium are nearly identical to the maximum HA level (max)
reached in the donor cultures after 24 hours (dotted line).
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Figure 5. Biochemical confirmation of wounding-induced HA accumulation
observed after direct injury, or following incubation with conditioned media
from injured cultures. REK lift cultures were injured by needle puncture, as
per the protocol illustrated in Figure 3. (a) Donor cultures were harvested at
6 hours after injury; (b) the conditioned media were transferred to recipient
cultures, which were then harvested 24 hours later. The cultures were lysed
for carbohydrate analyses on acrylamide gels using the FACE technique (see
Materials and Methods). The HA disaccharide bands (diHA) are shown at the
top. Graphs show relative induction of HA measured densitometrically; data
pooled from five independent experiments for (a) and six independent
experiments for (b); mean±SEM; *Po0.05.
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yield amplification products appropriately sized to allow
simultaneous display on a single gel (see Figure 6). Puncture
injury led to increased levels of Has2 and Has3, both in the
donor and recipient cultures (Figure 6a), with a significant
threefold increase for Has3 (Figure 6b). Has1, as reported
earlier in REKs, was not detectable (Pienimaki et al., 2001).
Expression of Hyal enzymes was essentially unchanged,
suggesting that elevated HA levels after injury may result
primarily from increased HA-synthetic activity rather than
from decreased HA catabolism.
Induction of HA synthesis after puncture wounding requires
activation of the EGFR pathway
Several lines of evidence suggested that EGFRs (synonyms
include EGFR, ErbB1, and HER1 receptors; see Harris et al.,
2003; Sahin et al., 2004; Pastore et al., 2008 for reviews) are
potentially involved in the HA response to injury. The Tammi
laboratory had shown in REK cells that several growth factors,
including exogenously-added EGF and KGF (FGF-7), are
strong inducers of HA synthesis through enhanced expression
of the Has2 gene (Pienimaki et al., 2001; Karvinen et al.,
2003; Saavalainen et al., 2005). Elevated HA levels after
retinoic acid treatment in the REK system require EGFR
activation (Pasonen-Seppanen et al., 2008). Interestingly,
many other laboratories have shown that migration of
keratinocytes and corneal epithelial cells after wounding is
blocked by inhibitors of the EGFR tyrosine kinase (Block
et al., 2004; Xu et al., 2006) and involves the shedding of
HER family ligands, including HB-EGF (Tokumaru et al.,
2000; Shirakata et al., 2005). Thus, we hypothesized that
EGFR and HER-family ligands might be linked to wounding-
induced HA synthesis. AG1478 is an inhibitor of the EGFR
kinase. In an initial titration, increasing doses of AG1478
were tested for their ability to block the induction of HA
caused by exogenously-added EGF; a concentration of 10 mM
AG1478 was maximally effective (Figure 7a, top row) while
not inhibiting HA levels in the control cells (Figure 7a, bottom
row). Using 10 mM AG1478, a puncture-transfer experiment
was then performed to examine changes in HA (Figure 7b).
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Figure 6. Increased HA production after injury coincides with an
upregulation of the Has2 and Has3 genes. Donor cultures were either not
injured (NO) or injured (YES) as indicated, then incubated for 6 hours and
donor cultures harvested for RNA analysis. Conditioned medium was
transferred from donor to recipient cultures and incubated for a further
6 hours, then harvested for reverse transcription (RT)-PCR analysis. (a)
Multiplex RT-PCR analyses of all the Has and Hyal genes, and b-actin (actin)
as an invariant control. Primer pairs were designed to yield well-separated
product sizes. Each PCR reaction was run separately, and the four reactions
were combined per lane to yield a convenient display. Note the apparent
upregulation of Has2 and Has3 in lanes 2 and 4. (b) Densitometric scanning
of bands. Data show changes relative to non-injured controls (mean±SD),
averaged from three independent culture experiments and normalized to
actin. (*) Increase is significant at Po0.05 level.
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Figure 7. Injury-induced HA production can be blocked by AG1478, an
inhibitor of the EGFR. (a) Titration experiment in which a positive control
(addition of exogenous EGF, 20 ngml1 for 6 hours) was applied in the
presence of different doses of inhibitor, as indicated. (b) Complete injury
experiment in which lift cultures were punctured 6 hours before transferring
the medium to a second (recipient) culture. Lanes 1–3, negative controls (no
injury). Lanes 4–6, positive controls (EGF). Lanes 7–9, injured cultures. The
REK lift cultures were incubated with AG1478 (10 mM) for 1 hour before injury,
or just after media transfer, as indicated above the figure. Lanes 1, 4, 7, no
inhibitor added; lanes 2, 5, 8, AG1478 added 1 hour before injury; lanes 3, 6,
9, AG1478 added at the point of media transfer. Recipient cultures were
incubated for 24 hours, harvested, and analyzed for HA content by FACE. Pre-
incubation with AG1478 appeared to block EGF- or puncture injury-induced
HA production in both the donor (data not shown) and recipient cultures
(shown above). AG1478 added at the point of medium transfer had a similar
effect in the recipient cultures.
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After puncture, the wounding-induced HA increase
(Figure 7b, compare lanes 1 and 7) was blocked when the
inhibitor was added either before puncture (lanes 2 and 8) or
at the time of media transfer (lanes 3 and 9). The inhibitor
blocked HA induction by positive control (exogenously-
added EGF) as expected (lanes 4–6).
To more directly examine the status of the EGFR, lift
cultures were punctured and the cell layer collected at
various time points after injury to examine the autopho-
sphorylation status of the receptor. EGFR was rapidly
phosphorylated on tyrosine residues within 15minutes, and
remained activated at 1 hour but showed downregulation by
3 hours (Figure 8). Overall, these data support the idea that
induction of HA after puncture injury requires activation of
the EGFR.
Identification of HB-EGF as an EGFR ligand released after
wounding of organotypic REK cultures
We next sought to identity EGF-family ligand(s) responsible
for HA upregulation. An antibody against murine EGF, from
Millipore/Upstate (no. 06-102), looked promising because it
had been characterized by its ability to neutralize EGFR
activity (Information about the neutralizing antibody (Milli-
pore/Upstate), and its ability to inhibit 3H-thymidine incor-
poration in primary cultured hepatocytes treated with
10 ngml1 EGF, was obtained from the certificate of analysis
from the company. Henceforth, we refer to this antibody as
the ‘‘neutralizing antibody’’). However, despite strong
evidence for EGFR activation after skin injury (Stoscheck
et al., 1992; Tokumaru et al., 2000; Shirakata et al., 2005),
EGF itself is not normally present in keratinocytes (Rittie
et al., 2006), a fact confirmed by western analysis of our 3D
REK cultures (data not shown). Therefore, we tested the
specificity of the neutralizing antibody against other factors
likely to be expressed in REKs, including amphiregulin (AR)
and HB-EGF (Figure 9a). Using recombinant proteins, we
found that the antibody cross-reacted with HB-EGF (lane 2),
but not with AR (lane 3). To establish whether the release of
activated HB-EGF occurs, REKs were injured, harvested at
various times, and soluble proteins (RIPA extracts) analyzed
on Western blots using a different antibody specific for
cleaved HB-EGF. No HB-EGF was detected in controls,
neither the pro-HB-EGF precursor (427 kDa) nor the active,
cleaved forms (Goishi et al., 1995). However, beginning
within 5minutes after injury and persisting at 6 hours,
peptides of the expected size for cleaved HB-EGF (B14
and B19 kDa; (Goishi et al., 1995)) were produced (Figure
9b). Thus, HB-EGF is a major ligand released after injury.
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Figure 8. Activation (phosphorylation) of EGFR occurs rapidly after
puncture injury. REK lift cultures were harvested at the indicated times after
needle puncture, and equal amounts of protein were separated on gels for
western analysis, as described in Materials and Methods. Arrows, locations of
p-EGFR (B178 kDa). Keratin 14 (K14) served as a loading control (B55 kDa).
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Figure 9. Specificity of a potential HB-EGF neutralizing antibody, and
release of cleaved HB-EGF after wounding. (a) An anti-mouse EGF antibody
from Millipore/Upstate (cat. no. 06-102) was analyzed for its specificity of
binding to the recombinant proteins listed above each lane (all from R&D
Systems). Antibodies to rat-EGF (cat. no. AF3214), human HB-EGF (AF259-
NA), or mouse Amphiregulin (AF989) were also from R&D Systems. Note the
cross-reactivity of antibody no. 06-102 with HB-EGF in lane 2. (b) Western
blot of REK lift cultures harvested at different times after acute puncture injury,
and probed with anti-human HB-EGF (R&D Systems, AF259-NA). Purified
recombinant human HB-EGF was used as a protein standard (downward
arrows). GAPDH served as a loading control.
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Requirement of HB-EGF for the HA-induction response to
wounding
As EGF is not expressed in keratinocytes (see above), inspite
of the anti-neutralizing antibody cross-reacting with HB-EGF
and reportedly capable of functionally blocking EGFR-
mediated pathways (Information about the neutralizing anti-
body (Millipore/Upstate), and its ability to inhibit 3H-
thymidine incorporation in primary cultured hepatocytes
treated with 10 ngml1 EGF, was obtained from the
certificate of analysis from the company.), we used it in an
attempt to block injury-induced HA accumulation. Pilot
titration studies were first performed to determine the
antibody concentration needed to completely block HA
stimulation from exogenously-added EGF; an effective
neutralizing dose was determined to be 5 mgml1 (Figure
10a). Using that dose, a complete puncture experiment was
carried out in which conditioned media from cultures injured
in the absence or presence of the antibody were transferred to
recipient cultures (Figure 10b, hatched bars). (For compar-
ison, quantitative data from experiments using AG1478 are
also included in these graphs). In either the donor or recipient
cultures, when compared to HA induction after puncture
alone (bars 5, 12), addition of the neutralizing antibody
before puncture (bar 7, 15) blocked the wounding-induced
increase in HA nearly completely. However, when the
neutralizing antibody was added at the time of media transfer
(bar 16), blockade by this antibody was only partial, that is, a
reduction to B50% of the HA maximum after wounding.
This was true even though AG1478 (inhibition of EGFR
kinase) was able to fully block HA induction (bars 13, 14) in
the recipient cultures. These results could be because the
neutralizing antibody only cross-reacts with an B19 kDa
band of HB-EGF, and not theB14 kDa form, which might be
differentially expressed in donor versus recipient cultures.
Alternatively, additional ErbB/HER growth factors may be
required. In summary, we conclude that HB-EGF is a very
important factor but perhaps not the only factor required to
mediate injury-induced HA synthesis.
DISCUSSION
Hyaluronic acid in the epidermis is of current interest
because recent studies indicate that HA is important for
regulating keratinocyte proliferation and differentiation
in vivo, both under homeostatic conditions (Tammi et al.,
2000; Passi et al., 2004) and in response to tissue trauma
(Tammi et al., 2005) and this paper). In this study, we used
organotypic 3D cultures comprising rat keratinocytes (REKs)
to study mechanisms of HA accumulation that occur in the
epidermal compartment after wounding (Passi et al., 2004).
Full-thickness needle (puncture) injury of these 3D cultures
led to elevated HA production as measured by two
independent methods, namely, histological detection with a
biotinylated HA-binding protein and biochemical detection
using enzymatic digestion and fluorophore-labeling of the
HA disaccharides. The time course of HA induction was quite
rapid, reaching 50% of maximum within 15minutes of
wounding, then peaking at 24 hours and subsiding at
48–72 hours. In contrast, induction of HA in murine
epidermis in vivo (observed both here and in an earlier
published study of tape-strip injury (Tammi et al., 2005)) was
measurable at 24 hours, reached a maximum at 3 days, and
persisted for at least 1 week. The reason that HA levels
remain elevated longer in the native epidermis than in the
organotypic model is unknown, but because the REK 3D
model contains no fibroblasts, it is possible that paracrine
factors from the dermis are necessary to sustain HA synthesis
by keratinocytes in vivo.
Increased HA expression after skin wounding in vivo can
be observed far from the site of injury. This phenomenon was
also seen in our culture system. Histological analysis of REK
3D cultures, injured in a small localized area, displayed HA
induction throughout the culture and confirmed that HA
induction is not confined to the immediate vicinity of the
injury. To explain this action at a distance, we hypothesized
that a soluble HA-inducing factor is released. Earlier reports
had shown that certain growth factors and cytokines can
induce the expression of HA-synthetic genes (Has2 and Has3)
in keratinocytes, and most of these are also released after
tissue injury, including the following: EGF (Pienimaki et al.,
2001; Pasonen-Seppanen et al., 2003), KGF (Karvinen et al.,
2003), IL-1b (Yamada et al., 2004), and IFN-g (Sayo et al.,
2002). Ligands of the EGFR/ErbB1/HER-1 family of receptors
were particularly strong candidates as soluble inducers of
HA, given published evidence that EGF (Pienimaki et al.,
2001; Pasonen-Seppanen et al., 2003), HB-EGF (Pasonen-
Seppanen et al., 2006), and TGF-alpha (Bachem et al., 1989)
were each capable of stimulating HA synthesis. Particularly
intriguing to us was a report showing that blockade of the
EGFR signaling pathway can prevent the migration of
cultured epithelial cells into an open wound in vitro (Block
et al., 2004), a process known to be influenced by HA in the
matrix (Rilla et al., 2002). Using AG1478 (an inhibitor of
EGFR tyrosine kinase), we showed that injury-induced HA
production was completely blocked by pre-treatment of the
REK 3D cultures with this inhibitor (Figures 7 and 10). HA
synthesis was prevented regardless of whether AG1478 was
added to the donor cultures before injury, or to the
conditioned media after injury. These data suggested,
although indirectly, that EGFR signaling is required to trigger
the increase in HA production. As a more direct means of
identifying ligand(s) responsible for HA induction, we found
an antibody (Millipore/Upstate no. 06-102) that is capable of
binding to the larger of the two proteolytic forms of rat HB-
EGF (Figure 9). As EGF (as opposed to HB-EGF) is not
produced in keratinocytes, even after wounding (data not
shown), we reasoned that any effect that the neutralizing
antibody might exert in functional experiments should be
because of its neutralizing effect upon HB-EGF. Indeed,
addition of the antibody to wounded cultures blocked HA
induction by B50% (Figure 10). This shows that HB-EGF is
an important ligand for the EGFR-mediated induction of HA
synthesis. It may or may not be the only factor involved.
Among the six ligands known to bind EGFR, namely, EGF,
HB-EGF, amphiregulin, epiregulin, betacellulin, and TGFa
(Harris et al., 2003), human keratinocytes have been reported
to express AR, HB-EGF, and epiregulin under non-stimulated
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conditions (Pastore et al., 2008). Here in rat keratinocytes, we
showed that HB-EGF is rapidly cleaved and expressed within
5minutes of injury. AR is constitutively expressed but not
altered after injury. Epiregulin, betacellulin, and TGFa remain
to be tested. However, on the basis of the frequency of reports
in which HB-EGF is produced (Shirakata et al., 2005; Rittie
et al., 2006; Mathay et al., 2008; Pasonen-Seppanen et al.,
2008) and released after epithelial injury (Tokumaru et al.,
2000; Xu et al., 2006), our proposition that HB-EGF is a major
ligand required for HA upregulation after wounding appears
solid.
As several growth factors had already been shown to
regulate one or more Has genes (Jacobson et al., 2000; Ijuin
et al., 2001; Karvinen et al., 2003; Pasonen-Seppanen et al.,
2003; Saavalainen et al., 2005), we suspected that HA
accumulation after injury is because of increased synthesis
(versus decreased catabolism) of HA. Expression of genes for
the major Has enzymes (Has1–3) and HA-degrading enzymes
(Hyal1–3) was measured in injured REK 3D cultures, and
Has2 and Has3 were upregulated, whereas expression
of the Hyals remained unchanged after injury (Figure 6).
Interestingly, the fact that Has3 is induced more than Has2 in
our system is consistent with reports that Has3 is
preferentially induced over Has2 in human keratinocytes
exposed to cytokines (Sayo et al., 2002) or to serum, to
stimulate the ‘‘wound repair transcriptome’’ (Qi et al., 2008).
From these data we conclude that the soluble factor (HB-EGF)
induces overall HA production by increasing the Has
gene expression. One caveat is that HA induction during
the initial phase (15minutes) after injury is too rapid to result
from transcriptional upregulation of Has genes, as the
appearance of new mRNA is typically expected to take a
few hours. We plan to test the hypothesis that a more rapid
mechanism, involving the stimulation of the pre-existing
Has2 and Has3, accounts for the initial surge in HA
synthesis.
On the basis of current data, our working hypothesis is
summarized in Figure 11. We have shown that physical
injury to epidermal keratinocytes (Figure 11, step 1) causes
the release of processed forms of HB-EGF. As the antibody we
used can only recognize the cleaved (and not the pro-) forms
of HB-EGF, the processed HB-EGF must have arisen from the
proteolytic cleavage of pro-HB-EGF through the action of a
metalloprotease (probably a ‘‘sheddase’’ of the ADAM
family; reviewed in (Sahin et al., 2004; Blobel, 2005)) as
demonstrated earlier in keratinocytes (Tokumaru et al.,
2000). Our experimental data showed that soluble HB-EGF
(step 3) was needed for binding to the EGFR/ErbB1 receptor,
and activation of the EGFR signaling pathway (that is,
receptor autophosphorylation) was required for HA synthesis
(step 4). Elevated transcription of Has3/Has2 (step 5), as
reflected by reverse transcription-PCR measurements of the
mRNAs (step 6), plays an important role. Ultimately, the
increased accumulation of HA (step 7) is observed. An
important question for the future is whether activation of the
HA receptor, CD44, might exert autoregulatory feedback
effects by interacting with EGFR (step 8). Mounting evidence
from the cancer literature has revealed functional interactions
between ErbB receptors (mainly ErbB2, but also the EGFR)
and CD44 (Turley et al., 2002; Misra et al., 2006; Ellis et al.,
2007), at least in cancer cell lines. This suggests the
tantalizing hypothesis that HA may be involved in auto-
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Figure 10. Injury-induced HA production can be blocked by an EGFR function-neutralizing antibody, showing that release of soluble EGFR-family ligands
(including HB-EGF) is required for new synthesis of HA. (a) Titration of neutralizing antibody (see Materials and Methods) for its ability to prevent EGF-induced
stimulation of HA synthesis. EGF was added at 20 ngml1 for 6 hours; the antibody was added at 5 or 25 mgml1. (b) Donor cultures were treated as illustrated in
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regulating its own synthesis through feedback interactions
between CD44 and EGFR.
In conclusion, we have shown that physical injury in an
organotypic model of epidermal keratinocytes causes the
release of HB-EGF and activation of EGFR, and that these are
prerequisites for a significant accumulation of HA. Given that
HA is involved in the regulation of keratinocyte migration
and in the epidermal hyperplastic response after injury
(Maytin et al., 2004), future studies to elucidate details of
this pathway should provide new opportunities for modifying
the wound healing response and for ameliorating clinical
conditions that involve excessive thickening of the epidermis.
MATERIALS AND METHODS
Source of reagents
All general reagents were purchased from Fisher Scientific (Hanover
Park, IL), and all tissue culture reagents were purchased from
Invitrogen (Carlsbad, CA), unless stated otherwise. The AG1478
inhibitor of EGFR tyrosine kinase was from EMD Biosciences
(Calbiochem, La Jolla, CA, cat. no. 658548). The EGF-neutralizing
antibody was a rabbit polyclonal from Millipore/Upstate, Lake
Placid, NY, Millipore cat. no. 06-102. Other antibodies are listed
under ‘‘western blot analyses’’.
Wounding of murine skin in vivo
All animal procedures were approved by the Institutional Animal
Care and Use Committee (IACUC) at our institution. C57BL/6J adult
mice, 8–10 weeks old, were anesthetized with a 0.04-ml injection of
a general anesthetic cocktail (ketamine 100mgml1; xylazine
20mgml1; acepromazine 10mgml1), and the upper dorsal back
was shaved and disinfected with 70% alcohol. Each animal received
a 1.5-cm full-thickness incisional wound that was closed with an
interrupted 6.0 nylon suture. All wounds were midline and made in
the same location. The wounded animals were housed in individual
cages for the duration of this study. At days 0, 3, 7, and 14 post-
wounding, the wound plus the surrounding tissue were harvested
and fixed overnight in 4% paraformaldehyde in a phosphate-
buffered saline (PBS) in preparation for HA analysis.
Preparation of collagen gels
Rat tail collagen type 1 (BD Biosciences Clontech, Palo Alto, CA)
was mixed with Hanks’ Salt Solution containing phenol red, and
buffered with 20mM HEPES. The pH was adjusted by adding small
(25 ml) aliquots of 1 N sodium hydroxide until a homogeneous, pale
orange solution was formed (at BpH 7.0). Care was taken to avoid
bubble formation during mixing. The solution was added to plastic
transwell inserts (1ml per insert; diameter 2.4 cm; pore size 3.0 mm;
Corning Incorporated, Corning, NY) housed in six-well plates.
Polymerized collagen fibrils were formed after incubation at 371C
for 2 hours in a 5% CO2 incubator. Once formed, the collagen gels
were stored immersed in PBS with 50 mgml1 of gentamycin sulfate
at 41C until required. Before use, the gels were soaked twice in
DMEM for 20minutes and finally equilibrated at 371C in DMEM in
the CO2 incubator.
Preparation of basement membranes
Maden Darby canine kidney (MDCK) cells (a gift from Donald
MacCallum, University of Michigan) were seeded onto the collagen
gels at a density of 2 105 cells per transwell in an MDCK medium
(DMEM supplemented with 4.5 g l1 of glucose, 100Uml1 of
penicillin, 100 mgml1 of streptomycin, 250 ngml1 of amphotericin
B, and 10% fetal bovine serum). The cells were grown for 21 days at
371C in a 5% CO2 incubator and the media were changed every 2
days. The cells were removed by detergent lysis, as follows: first, the
cells were immersed in a hypotonic lysis buffer (10mM Tris-HCl, pH
7.5, with 0.1% BSA and 0.1mM CaCl2) for 10minutes in a
humidified atmosphere at 371C. Then, they were treated with
0.2% deoxycholate in the hypotonic lysis buffer twice for 5minutes.
The complete removal of adherent MDCK cells was confirmed by
light microscopy. Collagen gels with the basement membranes on
their surfaces were stored immersed in PBS supplemented with
50 mgml1 of gentamycin sulfate at 41C until required. Before use,
the gels were soaked three times in PBS for 10minutes, then twice in
the MDCK medium for 20minutes before finally being equilibrated
in the MDCK medium overnight at 371C in a 5% CO2 incubator.
REK cell line
The REK cell line was originally developed by Donald MacCallum
from neonatal REKs (MacCallum and Lillie 1990). These keratino-
cytes possess the unique ability to stratify and terminally differentiate
in organotypic cultures without the aid of feeder fibroblasts. The
cells were grown in a REK medium (DMEM supplemented with
1 g l1 of glucose, 100Uml1 of penicillin, 100mgml1 of strepto-
mycin, 250 ngml1 of amphotericin B, 50mgml1 of gentamycin
sulfate, and 10% fetal bovine serum) at 371C in a 5% CO2
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Figure 11. Hypothetical model of injury-induced HB-EGF production and
upregulation of HA production. (See text for details).
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humidified incubator. Confluent REK monolayer cultures were
passaged using a trypsin/EDTA solution (0.05% trypsin, 0.02% EDTA
in Ca2þ /Mg2þ -free Earles’ balanced salt solution) at a ratio of 1:3.
Establishment of organotypic cultures
Rat epidermal keratinocytes were seeded onto inserts containing
collagen and a basement membrane at a density of 2 105 cells per
transwell. They were grown immersed in the REK medium for
48 hours. The cells were then ‘‘lifted’’ by removing the medium from
the upper chamber to expose the cells to air. The medium in the
lower chamber was changed daily (3.5ml) for the duration of the
experiment. The lifted cultures were grown for up to 5 days at 371C
in a 5% CO2 incubator.
Puncture wounding and harvesting for biochemical and
histological analyses
Fully stratified lift cultures (lifted for 5 days) were injured using a 28
gauge, 0.5-inch needle. The needle was pushed through the entire
lift culture, collagen layer, and porous nylon membrane, and this
was designated as 1 ‘‘puncture.’’ To randomly cover a circular
transwell of 25-mm diameter, 100 punctures were ‘‘randomly’’
administeredB2mm apart, delivering five rows (12, 11, 10, 9, and 8
punctures per row) on each side of the midline. To administer a more
localized pattern of injury, 100 punctures were made B1mm apart
in four parallel rows of 25 punctures grouped near the midline. After
injury, the cultures were incubated for designated times (typically
6 hours) at 371C in a 5% CO2 incubator. Lift cultures were then
harvested for analysis of carbohydrate (HA). The epithelial and
collagen components were separated and processed using the FACE
technique; see below. For molecular analysis of RNA or protein, the
cultures were cut in half and snap-frozen for later lysis in the
appropriate buffer. For histological analysis, the lift cultures were
fixed in histochoice fixative (Amresco, Solon, OH) before rolling and
embedding in paraffin, using the ‘‘cigarette roll’’ technique
described earlier (Passi et al., 2004).
Experiments involving the transfer of conditioned medium
In transfer experiments, the culture medium from the lower chamber
of a REK lift culture at 6 hours after injury was transferred from the
donor (injured) culture to the corresponding well of a recipient
(unwounded) culture, as shown in the schematic timeline in Figure 3.
The recipient REK lift cultures were incubated for a further 24 hours
at 371C in a 5% CO2 incubator, then harvested in the desired
manner for the experiment intended. In experiments where inhibitors
of the EGFR pathway were tested, an EGFR kinase inhibitor
(AG1478), a neutralizing antibody to EGFR ligands (5 mgml1,
rabbit polyclonal IgG; Millipore/Upstate 06-102), or an irrelevant,
IgG isotype-matched control antibody (5mgml1, anti-keratin 10,
Covance Inc., no. PRB-159P), was added 1hour before the time of
puncture injury or at the point of medium transfer.
Histological detection of HA
Hyaluronic acid visualization in histological sections was performed
using immunofluorescence microscopy, after labeling the HA in situ
with a biotinylated hyaluronan binding protein (bHABP; Seikagaku
Ltd, Tokyo, Japan) and Cy3-conjugated streptavidin (Jackson
Immunoresearch; West Grove, PA), as described (Passi et al.,
2004). Digitally-captured images were analyzed using IPLab
Spectrum (Signal Analytics, Vienna, VA), a software program that
allows one to trace out regions of interest within the tissue (done
either manually, or by setting a baseline threshold), followed by
background subtraction and summation to provide an integrated
intensity value. To establish that the observed signal was specific for
HA, histological sections were treated overnight with Hyal from
Streptomyces Hyal (2.5U in saline, overnight at 371C; Calbiochem
Inc.) or with Hyal from Streptococcus dysgalactiae (5mU in 0.1 M
ammonium acetate, overnight at 371C; Seikagaku Corporation,
Tokyo, Japan); see Figure 1.
Fluorophore-assisted carbohydrate electrophoresis of HA
The technique of Calabro et al. (2000) was used with several
modifications. REK lift cultures were excised from the transwell
insert (using a scalpel around the perimeter), and placed epidermis-
side down onto a 3 3 cm2 of blotting paper. The porous nylon
membrane and collagen gel were removed and discarded. The paper
with adherent cell layers was cut in two, to provide duplicate
samples (one for FACE analysis, the other for storage at 201C for
future use). For analysis, samples were sliced into small pieces and
digested in 1ml of a proteinase K solution (100 mgml1 of a
proteinase K (Invitrogen), 0.5% SDS, 0.1 M ammonium acetate) at
601C overnight. Following a brief vortex, the blotting paper was
removed and the samples were concentrated in a Speed-Vac to a
volume of 250 ml. Ice-cold 100% ethanol (1ml) was added and the
samples were incubated overnight at 201C. The samples were
centrifuged at 13,000 r.p.m. for 20minutes at 41C and the super-
natants were discarded. Ice-cold 75% ethanol (1ml) was added and
the samples were centrifuged for a further 20minutes as described
above. The supernatants were again removed and the samples were
air-dried at room temperature for 20minutes. Ammonium acetate
0.1 M (35 ml) was added to the dried pellets, which were then
resuspended by vortexing, heated to 1001C for 3minutes, and placed
on ice. Next, 1.4ml of a digestion solution (0.6 ml of 1% glacial acetic
acid, 0.4 ml of SD Hyal (2.5mU ml1; Seikagaku Corporation), and
0.4 ml of chondroitinase ABC (25mU ml1; Seikagaku Corporation))
was added to each sample, then mixed and incubated at 371C for
3 hours. A further 160 ml of 100% ice-cold ethanol was added to
each sample and mixed before being incubated overnight at 201C.
The samples were centrifuged for 20minutes (as above), and the
supernatants were collected and transferred to separate tubes. More
75% ice-cold ethanol (160 ml) was added to the pellets, which were
then centrifuged for 20minutes (as above). The supernatants from
these samples were then pooled with those collected earlier, and
dried to completion in a Speed-Vac. The dried samples were
resuspended in 20 ml of 0.1M ammonium acetate, transferred to
200ml tubes, then dried to completion for a second time. Next, 8 ml
of an AMAC dye solution (7.5% glacial acetic acid, 6.25mM
2-aminoacridone (Sigma, St Louis, MO), 625mM sodium cyanobor-
ohydride (Sigma)) was added and each sample was incubated
overnight at 371C in the dark. Finally, 3ml of 80% glycerol was
added to prepare each sample for gel analysis.
A Hoefer SE 600 vertical gel apparatus (Amersham Biosciences,
Buckinghamshire, UK) was used for sample separations. Each sample
was loaded and run on a 20% acrylamide gel (20ml acrylamide
(40% 37.5:1; Bio-Rad, Hercules, CA), 4ml of Tris-acetate (400mM;
pH 7), 1ml of glycerol, and 15ml of H2O) in 1 TBE buffer for
2 hours at 41C). The fluorescent disaccharide bands were visualized
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by illumination with 365nm UV light (Ultra Lum Transillumninator),
and the fluorescence emission was collected after passage through an
ethidium bromide orange barrier filter onto a Quantix cooled CCD
camera, as described in detail elsewhere (Calabro et al., 2000). The
images were analyzed using the Gel-Pro Analyzer 3.0 program
(Media Cybernetics, Bethesda, MD).
Reverse transcription-PCR analysis of Has and Hyal gene
expression
Rat epidermal keratinocyte lift cultures were excised from the transwell
inserts and placed onto blotting paper, as described above. Half of this
sample was sliced up and submerged in 1ml of a TRIZOL reagent
(Invitrogen), vortexed, and stored overnight at 801C. The next day,
the samples were thawed on ice and the blotting paper was removed.
Chloroform (200ml) was added to each sample, mixed by inversion,
and incubated on ice for 5minutes. The samples were centrifuged at
13,000 r.p.m. for 20minutes at 41C with the brake off. The upper,
aqueous phase of each sample (500ml) was transferred to a second
tube containing 500ml of isopropanol. The samples were mixed and
precipitated overnight at 201C, then centrifuged at 13,000 r.p.m. for
15minutes at 41C. The supernatants were removed, and 1ml of 100%
ice-cold ethanol was added. Samples were centrifuged as described
above and the supernatants were again discarded. One ml of 70% ice-
cold ethanol was added, and the samples were centrifuged for a third
time. After removal of the supernatant, the samples were air-dried for
1hour at room temperature. Purified RNA samples were resuspended
in 20ml of H2O and stored at 801C.
Semi-quantitative PCR was performed using the random hexamer
method. Sample RNA (1 mg) was added to 250 ng random primers
(Invitrogen) and 1ml 10mM dNTP mix (Invitrogen). The mixture was
heated for 5minutes at 651C, then placed on ice. To this mixture,
4ml of 5 First Strand buffer, 1 ml of 0.1M dithiothreitol, 1 ml of
RNaseOUT (40U ml1), and 1ml of Superscript III (200U ml1)
reverse transcriptase (all from Invitrogen) were added and the
mixture was heated for 5minutes at 251C, for 60minutes at 501C and
for 15minutes at 751C. Then, 1ml of the generated cDNA was used
per 25ml of PCR reaction as follows: 1ml of cDNA was mixed with
5ml of GoTaq 5 colorless buffer (with 7.5mM MgCl2; Promega,
Madison, WI), 0.1 ml of GoTaq polymerase (5U ml1 l1; Promega),
0.5 ml of dNTPs (10mM), 2.5 ml of sense strand primer (10 mM) and
2.5 ml of antisense strand primer (10 mM), and 13.4 ml of H2O. The
primer sequences, predicted product sizes, TMs, and cycle numbers
are given in Table S1. PCR was performed using a Mastercycler
Personal thermal cycler (Eppendorf, Westbury, NY). Amplification
for each primer set consisted of a preliminary denaturation at 941C
for 5minutes, followed by a cycle of 941C for 30 s, a TM of 60/651C
for 30 s, and an elongation at 721C for 1minute. A final elongation
step at 721C for 15minutes concluded the amplification. Each
reaction product (5 ml) was analyzed by agarose gel electrophoresis
(2.5% agarose gel; 1 TAE buffer containing 0.5mgml1 of
ethidium bromide; 1.5 hours at 90V). The gels were visualized and
digitally photographed under UV light, and densitometry was
performed using IPLab Spectrum software.
Western blot analyses of phosphorylated-EGFR and EGF-family
ligands
The REK lift cultures were harvested for protein as follows:
the cell layer was separated from the collagen gel and placed
directly into 100ml of RIPA buffer (PBS, pH 7.4 with 1% Nonidet
P-40 (Sigma), 0.5% sodium deoxycholate (Sigma), 0.1% SDS,
100mgml1 of PMSF (USB Scientific, Cleveland, OH), 100 mgml1
of aprotinin (USB Scientific), and 10 mgml1 of sodium orthovana-
date (Sigma). The samples were vortexed briefly and incubated on
ice for 20minutes. After a brief (4 seconds) sonication, samples
were centrifuged for 10minutes at 13,000 r.p.m. at 41C. The
supernatants were transferred to new tubes and stored at 801C
until required.
Protein concentration was determined using the Bio-Rad Protein
Assay Kit (Bio-Rad) as per the manufacturers’ protocol. Twenty mg of
protein from each sample was then resolved by SDS-PAGE under
reducing conditions. For the detection of phosphorylated-EGFR, the
samples were resolved using 10% Bis-Tris gels in NuPage MOPS
SDS running buffer (Invitrogen). For the detection of all other
proteins, 4–12% pre-cast NuPage Novex Bis-Tris gels (Invitrogen)
and NuPage MES SDS running buffer (Invitrogen) were used. The
samples were then transferred onto Immobilon-P membranes
(Millipore) using NuPage transfer buffer (Invitrogen) at 100V for
1.5 hours. The membranes were incubated in a blocking buffer
(TBST containing 5% non-fat dried milk) for 30minutes at room
temperature, then incubated with the desired primary antibody in
the blocking buffer overnight at 41C, using the following antibody
dilutions: anti-phosphorylated-EGFR [pY1068 44-788G] 1:300 (Invi-
trogen); anti-GAPDH [FL-335] 1:200 (Santa Cruz, Santa Cruz, CA);
anti-mouse EGF (neutralizing 06-102) 1:100 (Millipore); anti-rat EGF
(AF3214) 1:200 (R&D Systems, Minneapolis, MN); anti-mouse AR
(AF989) 1:200 (R&D Systems); and anti-human HB-EGF (AF259NA)
1:500 (R&D Systems) or anti-mouse K14 (PRB-155P) 1:5000
(Covance, Princeton, NJ). After washing the membranes 3 times for
5minutes per wash in a Tris-saline buffer (100mM Tris, 0.9% NaCl,
0.1% Triton-X100), the blots were incubated with the desired
horseradish peroxidase-secondary antibody at 1:20,000 dilution in
blocking buffer for 1 hour at room temperature, using the following
antibodies: goat-anti rabbit IgG (111-035-003); donkey anti-sheep
IgG (713-35-003); and donkey anti-goat IgG (705-035-147) (all
Jackson). After three, 5minutes washes with the Tris-saline buffer,
the proteins were visualized using the ECL-Plus detection reagent
(GE Healthcare, Little Chalfont, Buckinghamshire, UK) following the
manufacturers’ instructions, and the HyBlot CL autoradiography film
(Denville Inc., Metuchen, NJ).
Statistics
Two-sample t-tests were used to compare the difference between
data points of experimental conditions and untreated controls. A
P-value of 0.05 or less was considered statistically significant.
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